Insider Trading & Ownership - ZANTE GREG

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ZANTE GREG
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-10-28
Sale
2024-10-28
9:48 pm
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
131,687$76.61$10,089,164302,366
(Direct)
View
2024-07-30
Sale
2024-07-31
4:05 pm
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
16,136$57.15$922,212187,052
(Direct)
View
2024-05-03
Sale
2024-05-03
8:51 pm
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
66,756$74.69$4,986,008239,105
(Direct)
View
2024-01-04
Sale
2024-01-04
9:35 pm
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
15,000$17.9$268,500335,730
(Direct)
View
2023-04-17
Sale
2023-04-18
7:07 pm
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
7,500$20$150,000149,279
(Direct)
View
2023-04-11
Sale
2023-04-13
5:13 pm
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
97,839$18$1,761,310366,823
(Direct)
View
2023-03-30
Sale
2023-04-03
7:24 pm
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
161,940$17.19$2,784,219149,279
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-28
Exercise
2024-10-28
9:48 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
51,000$8.52302,366
(Direct)
View
2024-10-28
Exercise
2024-10-28
9:48 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
26,000$5.8302,366
(Direct)
View
2024-10-28
Exercise
2024-10-28
9:48 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
12,750$7.77302,366
(Direct)
View
2024-10-28
Exercise
2024-10-28
9:48 pm
2021-01-03
2030-01-03
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
94,001$0302,366
(Direct)
View
2024-10-28
Exercise
2024-10-28
9:48 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
4,251$4.68302,366
(Direct)
View
2024-07-29
Option Award
2024-07-31
4:05 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
28,334$0187,052
(Direct)
View
2024-05-03
Exercise
2024-05-03
8:51 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
30,000$4.88239,105
(Direct)
View
2024-05-03
Exercise
2024-05-03
8:51 pm
2021-03-31
2030-03-31
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
34,249$0239,105
(Direct)
View
2024-05-03
Exercise
2024-05-03
8:51 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
4,249$4.68239,105
(Direct)
View
2024-03-27
Option Award
2024-03-27
8:50 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
31,667$0207,361
(Direct)
View
2024-03-27
Tax Withholding
2024-03-27
8:50 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
16,610$83.34207,361
(Direct)
View
2024-03-01
Option Award
2024-03-04
7:50 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
31,667$0192,304
(Direct)
View
2024-03-01
Tax Withholding
2024-03-04
7:50 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
20,093$85.22192,304
(Direct)
View
2024-01-03
Tax Withholding
2024-01-04
9:35 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
49,122$17.4335,730
(Direct)
View
2024-01-03
Option Award
2024-01-04
9:35 pm
2025-01-03
2034-01-03
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
253,334$0335,730
(Direct)
View
2024-01-04
Tax Withholding
2024-01-04
9:35 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
13,872$18.58335,730
(Direct)
View
2023-04-17
Exercise
2023-04-18
7:07 pm
2018-08-31
2028-08-31
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
7,500$0149,279
(Direct)
View
2023-04-17
Exercise
2023-04-18
7:07 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
7,500$13.07149,279
(Direct)
View
2023-04-11
Exercise
2023-04-13
5:13 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
30,000$4.88366,823
(Direct)
View
2023-04-11
Exercise
2023-04-13
5:13 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
52,000$5.8366,823
(Direct)
View
2023-04-11
Exercise
2023-04-13
5:13 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
7,339$7.77366,823
(Direct)
View
2023-04-11
Exercise
2023-04-13
5:13 pm
2021-01-03
2030-01-03
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
97,839$0366,823
(Direct)
View
2023-04-11
Exercise
2023-04-13
5:13 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
8,500$4.68366,823
(Direct)
View
2023-03-30
Exercise
2023-04-03
7:24 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
12,250$4.65149,279
(Direct)
View
2023-03-30
Exercise
2023-04-03
7:24 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
32,000$8.52149,279
(Direct)
View
2023-03-30
Exercise
2023-04-03
7:24 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
42,000$7.69149,279
(Direct)
View
2023-04-03
Exercise
2023-04-03
7:24 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
30,911$7.77149,279
(Direct)
View
2023-04-03
Option Award
2023-04-03
7:24 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
56,667$0149,279
(Direct)
View
2023-03-30
Exercise
2023-04-03
7:24 pm
2020-01-15
2029-01-15
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
124,661$0149,279
(Direct)
View
2023-04-03
Tax Withholding
2023-04-03
7:24 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
55,166$17.57149,279
(Direct)
View
2023-03-30
Exercise
2023-04-03
7:24 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
7,500$4.12149,279
(Direct)
View
2023-01-03
Tax Withholding
2023-01-04
6:25 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
23,933$8.52389,057
(Direct)
View
2022-12-30
Tax Withholding
2023-01-04
6:25 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
19,697$9.4389,057
(Direct)
View
2023-01-04
Tax Withholding
2023-01-04
6:25 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
20,708$8.42389,057
(Direct)
View
2023-01-03
Option Award
2023-01-04
6:25 pm
2024-01-03
2033-01-03
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
314,900$0389,057
(Direct)
View
2022-01-03
Option Award
2022-01-05
7:13 pm
2023-01-03
2032-01-03
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
173,333$0256,304
(Direct)
View
2022-01-04
Tax Withholding
2022-01-05
7:13 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
8,835$4.62256,304
(Direct)
View
2022-01-03
Tax Withholding
2022-01-05
7:13 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
3,097$4.88256,304
(Direct)
View
2021-09-28
Option Award
2021-09-30
5:43 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
6,667$094,485
(Direct)
View
2021-09-28
Tax Withholding
2021-09-30
5:43 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
2,306$6.594,485
(Direct)
View
2021-01-19
Tax Withholding
2021-01-19
6:25 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
808$6.6889,751
(Direct)
View
2021-01-04
Tax Withholding
2021-01-06
4:28 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
2,787$5.8168,559
(Direct)
View
2021-01-04
Option Award
2021-01-06
4:28 pm
2022-01-04
2031-01-04
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
149,450$0168,559
(Direct)
View

Ownership
2021-01-06
4:22 pm
N/A
N/A
Viking Therapeutics Inc.VKTXZANTE GREG
Chief Financial Officer
0$0191,146
(Direct)
View